Gene editing in T cell therapy
2017
Abstract The adoptive transfer of engineered T cells for the treatment of cancer, autoimmunity, and infectious disease is a rapidly growing field that has shown great promise. Gene editing holds tremendous potential for further improvements of T cell therapy. Here we review the applications of gene editing in various T cell therapies, focusing on antiviral strategies and cancer immunotherapies, and discuss the challenges and future prospects.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
121
References
13
Citations
NaN
KQI